MétaCan
Menu
Back to cohort
Record W3101654075 · doi:10.1136/jitc-2020-001583

Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

2020· review· en· W3101654075 on OpenAlexaff
Brian Gastman, Piyush K. Agarwal, Adam Berger, Genevieve M. Boland, Stephen Broderick, Lisa H. Butterfield, David R. Byrd, Peter E. Fecci, Robert L. Ferris, Yuman Fong, Stephanie L. Goff, Matthew M. Grabowski, Fumito Ito, Michael Lim, Michael T. Lotze, Haider Mahdi, Mokenge Malafa, Carol D. Morris, Pranav Murthy, Rogerio I. Neves, Adekunle Odunsi, Sara I. Pai, Sangeetha Prabhakaran, Steven A. Rosenberg, Ragheed Saoud, Jyothi Sethuraman, Joseph J. Skitzki, Craig L. Slingluff, Vernon K. Sondak, John B. Sunwoo, Simon Turcotte, Cecilia C.S. Yeung, Howard L. Kaufman

Bibliographic record

VenueJournal for ImmunoTherapy of Cancer · 2020
Typereview
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsCentre Hospitalier de l’Université de Montréal
FundersNational Cancer InstituteSociety for Immunotherapy of Cancer
KeywordsMedicineImmunotherapySubspecialtyClinical trialMedical physicsCancer immunotherapyCancerOncologyIntensive care medicineInternal medicinePathology

Abstract

fetched live from OpenAlex

Immunotherapy is now a cornerstone for cancer treatment, and much attention has been placed on the identification of prognostic and predictive biomarkers. The success of biomarker development is dependent on accurate and timely collection of biospecimens and high-quality processing, storage and shipping. Tumors are also increasingly used as source material for the generation of therapeutic T cells. There have been few guidelines or consensus statements on how to optimally collect and manage biospecimens and source material being used for immunotherapy and related research. The Society for Immunotherapy of Cancer Surgery Committee has brought together surgical experts from multiple subspecialty disciplines to identify best practices and to provide consensus on how best to access and manage specific tissues for immuno-oncology treatments and clinical investigation. In addition, the committee recommends early integration of surgeons and other interventional physicians with expertise in biospecimen collection, especially in clinical trials, to optimize the quality of tissue and the validity of correlative clinical studies in cancer immunotherapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.086
metaresearch head score (Gemma)0.066
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.914
Threshold uncertainty score0.456

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0860.066
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.004
Bibliometrics0.0050.004
Science and technology studies0.0010.002
Scholarly communication0.0040.004
Open science0.0060.004
Research integrity0.0080.010
Insufficient payload (model declined to judge)0.0030.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.377
GPT teacher head0.577
Teacher spread0.200 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
DomainMethods
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations33
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueJournal for ImmunoTherapy of CancerSame topicCancer Immunotherapy and BiomarkersFrench-language works237,207